Latest news
Loading news…
Pulmocide is focused on the development of inhaled medicines for the treatment of viral and fungal infections of the respiratory tract.
Pulmocide on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Total Funding
$113.37M
Funding Rounds
4
Last Funding
Acquisitions
0
Monthly Visits
Contacts
14
About Pulmocide
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- London, England, United Kingdom
Pulmocide Funding Rounds
4 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Org Hq Country | ||
|---|---|---|---|---|---|
1–4 of 4Show
Page 1 / 1
Pulmocide Key People
CSO
Chief Commercial Officer
Chief Business Officer
14
professional contacts at Pulmocide
Contact execs at Pulmocide →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
FAQs about Pulmocide
People who checked this page also checked these
Browse the full Acquirezy directory.